MyFinsight
Home
Blog
About
Net loss
attributable to fulgent
-$29,530K
(-55.77%↓ Y/Y)
Net loss
attributable to...
-$189K
(36.79%↑ Y/Y)
Precision Diagnostics
$41,453K
Anatomic Pathology
$37,497K
Biopharma Services
$6,409K
Revenue From Contract
With Customer...
$30K
Net loss from
consolidated operations
-$29,719K
(-54.34%↓ Y/Y)
Interest income
$6,404K
(-20.85%↓ Y/Y)
Laboratory
Services-Operating Segments
$85,359K
Therapeutic Development
$30K
Other income, net
$38K
(-17.39%↓ Y/Y)
Loss before income
taxes
-$29,690K
(-37.97%↓ Y/Y)
Provision for (benefit
from) income taxes
$29K
(101.28%↑ Y/Y)
Total other income
(expense), net
$6,383K
(453.43%↑ Y/Y)
Revenue
$85,389K
(4.38%↑ Y/Y)
Interest expense
$59K
(247.06%↑ Y/Y)
Operating loss
-$36,073K
(-82.99%↓ Y/Y)
Gross profit
$25,679K
(-25.43%↓ Y/Y)
Cost of revenue
$59,710K
(26.06%↑ Y/Y)
Total operating
expenses
$61,752K
(14.04%↑ Y/Y)
General and
administrative
$27,195K
(3.04%↑ Y/Y)
Selling and marketing
$15,228K
(23.95%↑ Y/Y)
Research and development
$14,554K
(7.97%↑ Y/Y)
Amortization of intangible
assets
$2,603K
(30.80%↑ Y/Y)
Intangible impairment loss
$2,172K
Back
Back
Income Statement
Fulgent Genetics, Inc. (FLGT)
Fulgent Genetics, Inc. (FLGT)
source: myfinsight.com